IRIS
BISECCO, Alvino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.108
NA - Nord America 3.754
AS - Asia 3.139
SA - Sud America 514
Continente sconosciuto - Info sul continente non disponibili 281
AF - Africa 49
OC - Oceania 7
AN - Antartide 1
Totale 14.853
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.381
US - Stati Uniti d'America 3.632
IT - Italia 1.279
SG - Singapore 980
CN - Cina 645
HK - Hong Kong 548
IE - Irlanda 483
BR - Brasile 409
VN - Vietnam 404
DE - Germania 182
GB - Regno Unito 182
KR - Corea 139
AT - Austria 132
IN - India 120
JP - Giappone 111
FR - Francia 96
UA - Ucraina 79
SE - Svezia 63
CA - Canada 57
NL - Olanda 50
TR - Turchia 48
AR - Argentina 47
FI - Finlandia 43
GR - Grecia 32
BD - Bangladesh 30
MX - Messico 30
BE - Belgio 23
PL - Polonia 21
IQ - Iraq 17
EC - Ecuador 16
CO - Colombia 15
ID - Indonesia 13
ES - Italia 11
PH - Filippine 11
PK - Pakistan 11
ZA - Sudafrica 11
CR - Costa Rica 10
MA - Marocco 9
IR - Iran 8
MY - Malesia 8
PY - Paraguay 8
AU - Australia 7
CL - Cile 7
EG - Egitto 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
SA - Arabia Saudita 6
CH - Svizzera 5
LT - Lituania 5
NI - Nicaragua 5
VE - Venezuela 5
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
IS - Islanda 4
KE - Kenya 4
PT - Portogallo 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
RO - Romania 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AM - Armenia 2
BG - Bulgaria 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SM - San Marino 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
HU - Ungheria 1
Totale 14.567
Salva come PNG Salva come JPEG
Città #
Moscow 1.610
Hong Kong 526
San Jose 491
Dublin 482
Singapore 465
Ashburn 343
Santa Clara 343
Council Bluffs 242
Chandler 173
Naples 164
Ho Chi Minh City 139
Seoul 138
Jacksonville 128
Vienna 119
Hefei 114
Los Angeles 104
Beijing 103
Milan 99
Hanoi 96
Ann Arbor 80
New York 77
Rome 67
Bengaluru 65
Caserta 65
Dallas 62
Princeton 56
Roxbury 52
The Dalles 52
Medford 42
São Paulo 41
Bremen 40
Munich 40
Napoli 33
Orem 29
Aversa 26
Nuremberg 24
Da Nang 23
London 23
Nanjing 23
Norwalk 23
Amsterdam 21
Brussels 21
Wilmington 21
Phoenix 20
Chicago 19
Woodbridge 19
Haiphong 18
Atlanta 17
Miano 17
San Francisco 17
Stockholm 17
Memphis 16
Montreal 16
Warsaw 16
Turin 15
Cambridge 14
Frankfurt am Main 14
Miami 14
Tokyo 14
Boardman 13
Des Moines 13
Genoa 13
Chennai 12
Falkenstein 12
Verona 12
Brasília 11
Brooklyn 11
Kochi 11
Mexico City 11
Reggio Emilia 11
Rio de Janeiro 11
Turku 11
Bologna 10
Boston 10
Denver 10
Guangzhou 10
Manchester 10
Seattle 10
Toronto 10
Baghdad 9
Istanbul 9
Jinan 9
Newark 9
Thái Bình 9
Casoria 8
Florence 8
Helsinki 8
Houston 8
Hải Dương 8
Lappeenranta 8
Quarto 8
San José 8
San Polo 8
Afragola 7
Ercolano 7
Johannesburg 7
Mumbai 7
Ninh Bình 7
Sala Consilina 7
Shanghai 7
Totale 7.536
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 676
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 371
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 230
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 220
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 217
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 211
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 210
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 202
Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis 189
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 187
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 187
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 187
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 185
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 183
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 180
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 179
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 178
Translational research on cognitive impairment in chronic kidney disease 176
Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS) 173
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 171
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 170
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 167
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 167
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 166
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 161
Chemotherapy-related cognitive impairment and kidney dysfunction 160
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 160
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 159
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 159
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 156
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 154
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 154
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 153
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 152
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 151
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 151
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 150
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 149
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 149
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 148
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 146
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 146
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 145
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 144
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 144
Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis 142
Functional gradients reveal cortical hierarchy changes in multiple sclerosis 141
Signs and symptoms of COVID-19 in patients with multiple sclerosis 141
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 141
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 141
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 140
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 140
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 138
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 137
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 137
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 135
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 132
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 132
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 132
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 131
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 131
Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): A longitudinal MRI one-year study 130
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 128
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: The importance of intrathecal MOG-IgG synthesis 126
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 126
The relationship between biological sex, cognitive reserve, and cognition in multiple sclerosis 124
Longitudinal assessment of cognitive function in patients with non-relapsing MOG-IgG associated disease 124
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 123
Readability Analysis of Online Headache and Migraine Information 123
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 122
Functional plasticity of the visual system in multiple sclerosis. 122
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 122
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 121
Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis 118
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 117
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 115
Impact of post-contrast MRI in the definition of active multiple sclerosis 114
Two Unexpected Cases of Rosacea during Fingolimod Therapy 113
Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study 111
Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study. 107
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 107
Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study 104
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability 104
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 98
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 98
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 97
Listening to the neurological teams for multiple sclerosis: the SMART project 97
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 95
Lifespan normative data on rates of brain volume changes 93
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 92
Psychological resilience explains functional variability across people with multiple sclerosis – Commentary 88
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 84
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 82
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap 76
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 75
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease 73
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 73
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis 73
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications 59
The role of the intestinal microbiome in cognitive decline in patients with kidney disease 56
Totale 14.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 0 0 0 23 123 22 34 23 32 61 37 116
2022/2023867 100 14 23 54 82 57 3 38 439 18 16 23
2023/2024671 36 24 39 75 143 73 63 20 13 16 78 91
2024/20251.904 18 20 27 67 316 234 222 138 286 261 179 136
2025/20268.159 358 492 428 358 673 4.067 688 347 246 230 188 84
2026/20271.594 136 296 548 614 0 0 0 0 0 0 0 0
Totale 14.853